Beth Hecht sold Xeris Biopharma Holdings ($XERS) shares on the open market seven times over the past year for a total of about $809,000. Her most recent sale occurred on March 2, 2026. These transactions rank her 5,395th out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions per seller. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 16667 | $5.99 | 1,209,840.0000 | 177,617,307 | 1.36% | 0.01% |
| March 2, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 16567 | $6.24 | 1,226,607.0000 | 177,617,307 | 1.33% | 0.01% |
| March 2, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 100 | $7.06 | 1,226,507.0000 | 177,617,307 | 0.01% | 0.00% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 24266 | $7.36 | 1,259,841.0000 | 177,617,307 | 1.89% | 0.01% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 46914 | $7.36 | 1,284,107.0000 | 177,617,307 | 3.52% | 0.03% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 98375 | $7.36 | 1,331,021.0000 | 177,617,307 | 6.88% | 0.06% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | A | Common Stock | 121293 | $0.00 | 1,429,396.0000 | 177,617,307 | 9.27% | 0.07% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | A | Stock Option (Right to Buy) | 162162 | $0.00 | 162,162.0000 | 177,617,307 | 9999.99% | 0.09% |
| Feb. 2, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 16667 | $7.45 | 1,243,174.0000 | 177,617,307 | 1.32% | 0.01% |
| Jan. 2, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 16667 | $7.43 | 1,308,103.0000 | 177,617,307 | 1.26% | 0.01% |
| Dec. 1, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 16667 | $7.01 | 1,320,176.0000 | 177,617,307 | 1.25% | 0.01% |
| Nov. 11, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 16667 | $7.40 | 1,336,843.0000 | 177,617,307 | 1.23% | 0.01% |
| March 20, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | S | Common Stock | 40000 | $5.43 | 1,353,510.0000 | 146,772,758 | 2.87% | 0.03% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 45909 | $3.56 | 1,306,885.0000 | 146,772,758 | 3.39% | 0.03% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 98375 | $3.56 | 1,208,510.0000 | 146,772,758 | 7.53% | 0.07% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | A | Common Stock | 185000 | $0.00 | 1,393,510.0000 | 146,772,758 | 15.31% | 0.13% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | A | Stock Appreciation Right | 300000 | $0.00 | 300,000.0000 | 146,772,758 | 9999.99% | 0.20% |
| Jan. 3, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 32039 | $3.61 | 1,352,794.0000 | 146,772,758 | 2.31% | 0.02% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 45909 | $2.46 | 1,380,802.0000 | 137,674,857 | 3.22% | 0.03% |
| Jan. 31, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 4448 | $2.11 | 1,540,323.0000 | 0 | 0.29% | 0.00% |
| Jan. 29, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 14037 | $2.11 | 1,544,771.0000 | 0 | 0.90% | 0.00% |
| Jan. 3, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 33488 | $1.12 | 1,506,835.0000 | 135,628,721 | 2.17% | 0.02% |
| Jan. 29, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 19675 | $2.66 | 1,426,711.0000 | 137,674,857 | 1.36% | 0.01% |
| Jan. 3, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 33488 | $2.24 | 1,446,386.0000 | 137,674,857 | 2.26% | 0.02% |
| Jan. 31, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 5784 | $1.24 | 1,479,874.0000 | 135,628,721 | 0.39% | 0.00% |
| Jan. 29, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | F | Common Stock | 21177 | $1.26 | 1,485,658.0000 | 135,628,721 | 1.41% | 0.02% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Hecht Beth | See Remarks | A | Common Stock | 750000 | $0.00 | 1,554,968.0000 | 137,674,857 | 93.17% | 0.54% |
| June 15, 2023 | Iterum Therapeutics plc | $ITRM | Hecht Beth | Director | M | Restricted Share Units | 15853 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.13% |
| June 15, 2023 | Iterum Therapeutics plc | $ITRM | Hecht Beth | Director | M | Ordinary Shares | 15853 | $0.00 | 18,839.0000 | 12,236,607 | 530.91% | 0.13% |